TABLE 1.
Recipient and donor demographicsa
| Tacrolimus/Prednisone | Tacrolimus/Prednisone/MMF | Overall | |
|---|---|---|---|
| N | 106 | 102 | 208 |
| Recipient age (yr) | 52.5±13.3 | 48.7±13.6* | 50.7±13.7 |
| (Range) | (19.3–84.1) | (18.8–72.5) | (18.7–84.1) |
| Repeat transplantation | 13 (12.2%) | 18 (17.6%) | 31 (14.9%) |
| PRA >40% | 6 (5.7%) | 5(4.9%) | 11 (5.3%) |
| >60 yr | 36 (34.0%) | 27 (26.5%) | 63 (30.3%) |
| Previous liver or heart transplant | 7 (6.6%) | 9 (8.8%) | 16 (7.7%) |
| Donor age (yr) | 33.8±20.9 | 35.5±22.6 | 34.5±21.7 |
| (Range) | (0.2–76.4) | (0.01–76.5) | (0.01–76.5) |
| ≥60 yr | 12 (11.3%) | 16 (15.7%) | 28 (13.5%) |
| <4yr | 14 (13.2%) | 11 (10.8%) | 25 (12.0%) |
| (En bloc) | |||
| Cold ischemia time | 28.8±8.7 | 32.2±9.5** | 30.5±9.2 |
| (Range) | (4.2–49.0) | (15.3–57.1) | (4.7–57.1) |
| Antigen match | 2.4±1.4 | 2.6±1.4 | 2.5±1.4 |
| Antigen mismatch | 3.2±1.5 | 3.1±1.5 | 3.1±1.5 |
| 0 Antigen mismatch | 6 (5.7%) | 11 (10.8%) | 17 (8.2%) |
a *
a *, P < 0.05;
**
P < 0.02.